LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 102 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q2 2024. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $207,878 | – | 9,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,790,462 | $75,426,188 | 4.36% |
| Nan Fung Group Holdings Ltd | 144,570 | $3,907,727 | 4.17% |
| Ally Bridge Group (NY) LLC | 218,981 | $5,919,056 | 3.53% |
| Integral Health Asset Management, LLC | 1,100,000 | $29,733,000 | 2.82% |
| Parkman Healthcare Partners LLC | 694,178 | $18,763,631 | 2.51% |
| Lynx1 Capital Management LP | 167,317 | $4,522,579 | 1.63% |
| RA Capital Management | 3,289,119 | $88,904,887 | 1.18% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,849 | $3,320,608 | 0.78% |
| Saturn V Capital Management LP | 71,442 | $1,931,077 | 0.73% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,940,500 | $79,481,715 | 0.38% |